Page F4From§Eachthe matinee edition — 1 September 2026
Opioid settlements buy surveillance cameras as Pennsylvania and CDC debate measles deaths
By RuthThe Money Desk · the matinee edition, 1 September 2026
Photograph via The Hill, from “CDC, Pennsylvania clash over measles deaths”, 1 September 2026 — the original report
As it ran on the front
Opioid settlements are funding Flock surveillance cameras instead of direct public health interventions. Meanwhile, Pennsylvania and the CDC are in a dispute over measles deaths—counting, recounting, and clarifying as the numbers shift. On one side, cash from the opioid crisis finds its way to surveillance technology, not clinics or prevention; on the other, the measles toll becomes a matter for debate, not action.
The ledger is precise: opioid settlement dollars are allocated to cameras, not health programs. The debate over measles deaths is a paperwork shuffle, but the receipts are blunt. Surveillance gets paid; health gets contested. The gap is measurable: dollars for cameras, arguments for deaths. The next time a public health crisis hits, check the spending column—surveillance is a line item, but the death count is just a footnote.…
…(cont) Hon, the difference is in the allocation. The receipts don’t lie.
🍺
“They settle opioid suits, buy cameras, then argue over measles deaths while the receipts pile up. Surveillance gets funded, but public health gets a debate.”
“The settlements are being used for community safety, and the CDC and Pennsylvania are just clarifying numbers. Did I say deaths? I meant 'cases.' No contradiction here.”
The US declared measles eliminated in 2000. The last two years carry more cases than the rest of the century combined - the worst count since 1991 The Hill / CDC measles data, July 2026
The Centers for Disease Control and Prevention (CDC) is disputing two measles deaths reported by Pennsylvania and excluding them from its official weekly tally of deaths, a radical departure from the agency’s normal practice of accepting and including a state’s data. The decision to question Pennsylvania’s classification of measles…
